SomnoMed Limited (FRA:RJV)
Germany flag Germany · Delayed Price · Currency is EUR
0.3660
+0.0020 (0.55%)
At close: Jan 22, 2026

SomnoMed Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
-3.46-12.24-8-4.44-1.19
Depreciation & Amortization
4.564.353.973.383.29
Other Amortization
1.192.461.610.550.55
Loss (Gain) From Sale of Assets
-00.01---
Stock-Based Compensation
1.950.081.041.190.03
Other Operating Activities
0.510.390.64-0.73-0.07
Change in Accounts Receivable
-4.17-1.730.37-0.37-2.86
Change in Inventory
-0.69-2.2-1.01-0.76-0.09
Change in Accounts Payable
5.352.17-1.582.251.94
Change in Income Taxes
1.08-0.05-0.650.1-
Change in Other Net Operating Assets
0.630.640.030.61.06
Operating Cash Flow
7.78-6.03-3.881.862.71
Operating Cash Flow Growth
----31.34%-47.86%
Capital Expenditures
-2.42-1.39-3.14-1.01-2.15
Sale of Property, Plant & Equipment
----0.04
Sale (Purchase) of Intangibles
-1.56-3.95-3.28-7.78-1.98
Investment in Securities
---0.32-0.27
Investing Cash Flow
-3.98-5.34-6.41-8.47-4.37
Long-Term Debt Issued
--15.44.54-
Long-Term Debt Repaid
-3.34-19.62-8.8-2.47-7.2
Total Debt Repaid
-3.34-19.62-8.8-2.47-7.2
Net Debt Issued (Repaid)
-3.34-19.626.612.08-7.2
Issuance of Common Stock
-38.08-0.010.4
Other Financing Activities
-0.04-2.070--
Financing Cash Flow
-3.3816.386.612.09-6.8
Foreign Exchange Rate Adjustments
0.69-0.78-0-0.94-0.6
Net Cash Flow
1.114.22-3.69-5.47-9.06
Free Cash Flow
5.36-7.42-7.020.850.55
Free Cash Flow Growth
---53.94%-83.90%
Free Cash Flow Margin
4.81%-8.10%-8.39%1.17%0.88%
Free Cash Flow Per Share
0.03-0.06-0.090.010.01
Cash Interest Paid
0.061.621.850.380.49
Cash Income Tax Paid
0.761.131.770.740.62
Levered Free Cash Flow
4.78-6.87-5.88-5.27-1.26
Unlevered Free Cash Flow
5.04-6.56-4.71-5.03-0.97
Change in Working Capital
3.05-1.07-3.141.910.1
Source: S&P Global Market Intelligence. Standard template. Financial Sources.